FDA notifications. FDA approves lipidatrophy drug.
D000328:Adult; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004343:Drug Implants; D017886:Durapatite / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008060:Lipodystrophy / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
D004343:Drug Implants; D017886:Durapatite